Inhibitors of Catechol-O-methyltransferase in the Treatment of Neurological Disorders

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 13, Iss. 3, 2013-09 ,pp. : 166-194

Bentham Science Publishers

Access to resources Recommend Favorite

Beneficial effects of co-administration of catechol-O-methyltransferase inhibitors and L-dihydroxyphenylalanine in rat models of depression

By Mannisto P.T.   Lang A.   Rauhala P.   Vasar E.  

European Journal of Pharmacology, Vol. 274, Iss. 1, 1995-02 ,pp. : 229-233

Elsevier

Access to resources Recommend Favorite

Treatment of Cognitive Deficits Associated with Schizophrenia: Potential Role of Catechol-O-Methyltransferase Inhibitors

By Apud José A.   Weinberger Daniel R.  

CNS Drugs, Vol. 21, Iss. 7, 2007-01 ,pp. : 535-557

Adis International

Access to resources Recommend Favorite

The Role of Catechol-O-Methyltransferase in Reward Processing and Addiction

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 11, Iss. 3, 2012-05 ,pp. : 306-323

Bentham Science Publishers

Access to resources Recommend Favorite

Catechol- O -Methyltransferase Inhibitors in Parkinson's Disease: Guidelines for Effective Use

By Davis T.L.  

CNS Drugs, Vol. 10, Iss. 4, 1998-10 ,pp. : 239-246

Adis International

Access to resources Recommend Favorite